Berkley Jensen Allergy Relief Recalled for Failed Quality Specifications
L. Perrigo Company is recalling Berkley Jensen Allergy Relief tablets due to failed product quality specifications involving impurities and degradation. Consumers should verify their lot numbers and expiration dates.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall of a drug product with failed quality control specifications for impurities and degradation products. No illnesses or injuries have been reported, but the product integrity issue represents a potential health risk, meeting the High severity threshold for risk-of-harm products without reported adverse events.
Plain-English summary
L. Perrigo Company is recalling Berkley Jensen Allergy Relief (Fexofenadine Hydrochloride) 180 mg tablets nationwide. The FDA classified this as a Class II recall due to failed impurities and degradation product specifications. Approximately 23,868 cartons of the affected product were distributed.
The recalled product consists of 150-count cartons distributed by BJ's Wholesale Club. The affected lots include: Lot #2DV1863 and 2HV2698 (Exp. 12/23), Lot #2GV1583 (Exp. 02/24), and Lot #2GV1950 and 2HV2697 (Exp. 01/24). The product NDC is 68391-847-47.
Consumers with affected lots should stop using the product and contact their pharmacy or BJ's Wholesale Club for a refund or replacement. Consult your healthcare provider if you have questions about your allergy medication alternatives.
The recalled product
- Product
- BERKLEY JENSEN ALLERGY RELIEF (FEXOFENADINE HYDROCHLORIDE)
- Brand
- BERKLEY JENSEN ALLERGY RELIEF
- Manufacturer
- L. Perrigo Company
- Category
- Drug — OTC Allergy Relief
- Hazard
- Affected units
- 23,868
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (8)
- Lot #:2DV1863
- 2HV2698
- Exp. date 12/23
- 2GV1583
- Exp. date 02/24
- 2GV1950
- 2HV2697
- Exp. Date 01/24.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 13 recalled by L. Perrigo Company under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 13 products in this recall →Related recalls
Same manufacturer · L. Perrigo Company
See all →- HighFexofenadine Hydrochloride Tablets Recalled for Failed Purity Specifications
FDA (Drugs) · 2023-07-19
- ModerateOTC Allergy Relief Tablets Recalled for Failed Manufacturing Specifications
FDA (Drugs) · 2023-07-19
- HighBASIC CARE Allergy Tablets Recalled Due to Failed Quality Specifications
FDA (Drugs) · 2023-07-19
- HighAllergy Relief Fexofenadine Tablets Recalled for Failed Impurity Specifications
FDA (Drugs) · 2023-07-19
- ModerateOTC Antihistamine Tablets Recalled for Failed Quality Specifications
FDA (Drugs) · 2023-07-19
Same hazard · impurity
See all →- ModerateHikma Recalls Ramipril Capsules Due to Process Impurity
FDA (Drugs) · 2026-09-02
- ModerateMedline Remedy Specialized Silicone Cream Recalled for Elevated Formaldehyde Levels
FDA (Drugs) · 2026-07-15
- SevereCinacalcet Hydrochloride Tablets Recalled for Elevated Impurity Levels
FDA (Drugs) · 2026-07-08
- HighDuloxetine 30mg delayed-release capsules exceed nitrosamine impurity interim limit
FDA (Drugs) · 2026-06-17
- HighDuloxetine 60mg delayed-release capsules exceed nitrosamine impurity interim limit
FDA (Drugs) · 2026-06-17